Bloch-Shilderman E - Search Results

1

Synergism Between Anticholinergic and Oxime Treatments Against Sarin-Induced Ocular Insult in Rats.

Gore A, Brandeis R, Egoz I, Turetz J, Nili U, Grauer E, Bloch-Shilderman E. Gore A, et al. Among authors: bloch shilderman e. Toxicol Sci. 2015 Aug;146(2):301-10. doi: 10.1093/toxsci/kfv092. Epub 2015 May 7. Toxicol Sci. 2015. PMID: 25956921

2

Transient and reversible nephrotoxicity of sarin in rats.

Bloch-Shilderman E, Levy A. Bloch-Shilderman E, et al. J Appl Toxicol. 2007 Mar-Apr;27(2):189-94. doi: 10.1002/jat.1204. J Appl Toxicol. 2007. PMID: 17154277

3

Subchronic exposure to low-doses of the nerve agent VX: physiological, behavioral, histopathological and neurochemical studies.

Bloch-Shilderman E, Rabinovitz I, Egoz I, Raveh L, Allon N, Grauer E, Gilat E, Weissman BA. Bloch-Shilderman E, et al. Toxicol Appl Pharmacol. 2008 Aug 15;231(1):17-23. doi: 10.1016/j.taap.2008.03.024. Epub 2008 Apr 11. Toxicol Appl Pharmacol. 2008. PMID: 18485435

4

Deterioration in brain and heart functions following a single sub-lethal (0.8 LCt50) inhalation exposure of rats to sarin vapor: a putative mechanism of the long term toxicity.

Allon N, Chapman S, Egoz I, Rabinovitz I, Kapon J, Weissman BA, Yacov G, Bloch-Shilderman E, Grauer E. Allon N, et al. Toxicol Appl Pharmacol. 2011 May 15;253(1):31-7. doi: 10.1016/j.taap.2011.03.007. Epub 2011 Mar 15. Toxicol Appl Pharmacol. 2011. PMID: 21419149

5

Efficacy assessment of various anticholinergic agents against topical sarin-induced miosis and visual impairment in rats.

Gore A, Brandeis R, Egoz I, Peri D, Turetz J, Bloch-Shilderman E. Gore A, et al. Toxicol Sci. 2012 Apr;126(2):515-24. doi: 10.1093/toxsci/kfs009. Epub 2012 Jan 12. Toxicol Sci. 2012. PMID: 22247005

6

Magnesium sulfate treatment against sarin poisoning: dissociation between overt convulsions and recorded cortical seizure activity.

Katalan S, Lazar S, Brandeis R, Rabinovitz I, Egoz I, Grauer E, Bloch-Shilderman E, Raveh L. Katalan S, et al. Among authors: bloch shilderman e. Arch Toxicol. 2013 Feb;87(2):347-60. doi: 10.1007/s00204-012-0916-1. Epub 2012 Sep 28. Arch Toxicol. 2013. PMID: 23052190

7

Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats.

Gore A, Bloch-Shilderman E, Egoz I, Turetz J, Brandeis R. Gore A, et al. Among authors: bloch shilderman e. Br J Pharmacol. 2014 May;171(9):2364-74. doi: 10.1111/bph.12586. Br J Pharmacol. 2014. PMID: 24428128 Free PMC article.

8

Propagation of damage in the rat brain following sarin exposure: Differential progression of early processes.

Lazar S, Egoz I, Brandeis R, Chapman S, Bloch-Shilderman E, Grauer E. Lazar S, et al. Among authors: bloch shilderman e. Toxicol Appl Pharmacol. 2016 Nov 1;310:87-97. doi: 10.1016/j.taap.2016.09.008. Epub 2016 Sep 14. Toxicol Appl Pharmacol. 2016. PMID: 27639427

9

Determining a threshold sub-acute dose leading to minimal physiological alterations following prolonged exposure to the nerve agent VX in rats.

Bloch-Shilderman E, Rabinovitz I, Egoz I, Yacov G, Allon N, Nili U. Bloch-Shilderman E, et al. Arch Toxicol. 2018 Feb;92(2):873-892. doi: 10.1007/s00204-017-2108-5. Epub 2017 Nov 10. Arch Toxicol. 2018. PMID: 29127449

10

Repetitive antidotal treatment is crucial in eliminating eye pathology, respiratory toxicity and death following whole-body VX vapor exposure in freely moving rats.

Bloch-Shilderman E, Yacov G, Cohen L, Egoz I, Gutman H, Gez R, Rabinovitz I, Nili U. Bloch-Shilderman E, et al. Arch Toxicol. 2019 May;93(5):1365-1384. doi: 10.1007/s00204-019-02401-0. Epub 2019 Feb 7. Arch Toxicol. 2019. PMID: 30729277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters